全文获取类型
收费全文 | 580篇 |
免费 | 41篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 26篇 |
妇产科学 | 11篇 |
基础医学 | 56篇 |
口腔科学 | 11篇 |
临床医学 | 73篇 |
内科学 | 166篇 |
皮肤病学 | 9篇 |
神经病学 | 26篇 |
特种医学 | 45篇 |
外科学 | 120篇 |
综合类 | 22篇 |
预防医学 | 24篇 |
眼科学 | 6篇 |
药学 | 28篇 |
肿瘤学 | 14篇 |
出版年
2018年 | 5篇 |
2016年 | 6篇 |
2015年 | 14篇 |
2014年 | 16篇 |
2013年 | 13篇 |
2012年 | 15篇 |
2011年 | 15篇 |
2010年 | 30篇 |
2009年 | 22篇 |
2008年 | 12篇 |
2007年 | 23篇 |
2006年 | 11篇 |
2005年 | 11篇 |
2004年 | 9篇 |
2003年 | 6篇 |
2002年 | 6篇 |
2001年 | 9篇 |
2000年 | 10篇 |
1999年 | 15篇 |
1998年 | 30篇 |
1997年 | 20篇 |
1996年 | 25篇 |
1995年 | 13篇 |
1994年 | 12篇 |
1993年 | 16篇 |
1992年 | 19篇 |
1991年 | 18篇 |
1990年 | 12篇 |
1989年 | 16篇 |
1988年 | 15篇 |
1987年 | 8篇 |
1986年 | 9篇 |
1985年 | 9篇 |
1984年 | 4篇 |
1983年 | 7篇 |
1982年 | 7篇 |
1980年 | 6篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1972年 | 3篇 |
1962年 | 3篇 |
1959年 | 15篇 |
1958年 | 16篇 |
1957年 | 14篇 |
1956年 | 10篇 |
1955年 | 15篇 |
1954年 | 19篇 |
1952年 | 5篇 |
1949年 | 3篇 |
1948年 | 4篇 |
排序方式: 共有640条查询结果,搜索用时 15 毫秒
91.
CD8-positive/T-cell receptor-negative (CD8(+)/TCR(-)) graft facilitating cells (FCs) are a novel cell population in bone marrow that potently enhance engraftment of hemopoietic stem cells (HSCs). Previously, we showed that the CD11c(+)/B220(+)/CD11b(-) plasmacytoid-precursor dendritic cell (p-preDC) FC subpopulation plays a critical but nonredundant role in facilitation. In the present study, we investigated the mechanism of FC function. We report that FCs induce antigen-specific CD4(+)/CD25(+)/FoxP3(+) regulatory T cells (Tregs) in vivo. The majority of chimeric Tregs were recipient derived. Chimeric Tregs harvested at ≥ 4 weeks after transplantation significantly enhanced engraftment of donor- and recipient-derived HSCs, but not third-party HSCs, in conditioned secondary recipients, demonstrating antigen specificity. Although Tregs were present 2 and 3 weeks after transplantation, they did not enhance engraftment. In contrast, week 5 and greater Tregs potently enhanced engraftment. The function of chimeric Tregs was directly correlated with the development of FoxP3 expression. Chimeric Tregs also induced significantly stronger suppression of T-cell proliferation to donor antigen in vitro. Removal of p-preDC FCs resulted in impaired engraftment of allogeneic HSCs and failure to produce chimeric Tregs, suggesting that the CD8α(+) p-preDC subpopulation is critical in the mechanism of facilitation. These data suggest that FCs induce the production of antigen-specific Tregs in vivo, which potently enhance engraftment of allogeneic HSCs. FCs hold clinical potential because of their ability to remain tolerogenic in vivo. 相似文献
92.
93.
Santosh K. Sanganalmath Adam B. Stein Yiru Guo Sumit Tiwari Greg Hunt Robert J. Vincent Yiming Huang Arash Rezazadeh Suzanne T. Ildstad Buddhadeb Dawn Roberto Bolli 《Journal of molecular and cellular cardiology》2009,47(4):528-535
We have previously reported that administration of granulocyte colony-stimulating factor (G-CSF) + Flt-3 ligand (FL) or G-CSF + stem cell factor (SCF) improves left ventricular (LV) function and halts LV remodeling at 35 d after myocardial infarction (MI). In the current study, we investigated whether these beneficial effects are sustained in the long term — an issue of fundamental importance for clinical translation. Mice undergoing a 30-min coronary occlusion followed by reperfusion received vehicle (group I), G-CSF + FL (group II), G-CSF + SCF (group III), or G-CSF alone (group IV) starting 4 h after reperfusion and were euthanized 48 wk later. LV structure and function were assessed by serial echocardiography before and at 48 h and 4, 8, 16, 32, and 48 wk after MI. During follow-up, mice in group I exhibited worsening of LV function and progressive LV remodeling. Compared with group I, both groups II and III exhibited improved LV EF at 4 wk after MI; however, only in group II was this improvement sustained at 48 wk. Group II was also the only group in which the decrease in infarct wall thickening fraction, the LV dilatation, and the increase in LV mass were attenuated vs. group I. We conclude that the beneficial effect of G-CSF+FL on postinfarction LV dysfunction and remodeling is sustained for at least 11 months, and thus is likely to be permanent. In contrast, the effect of G-CSF + SCF was not sustained beyond the first few weeks, and G-CSF alone is ineffective. To our knowledge, this is the first long-term study of cytokines in postinfarction LV remodeling. The results reveal heretofore unknown differential actions of cytokines and have important translational implications. 相似文献
94.
95.
96.
97.
98.
CD45 congenic mice have been used to study stem cell engraftment in the absence of alloreactivity. Recently, impaired engraftment was reported in this model and attributed to weak immune reactivity. We have confirmed that there is indeed low-level reactivity mediated by CD8(+) cells and alpha beta-TCR(+) T cells. B6 (CD45.2) recipients were conditioned with total body irradiation (TBI) and transplanted with increasing doses of B6 (CD45.1) bone marrow cells (BMCs). Although chimerism was present at 1 month in all recipients, durable engraftment did not occur with <150 cGy of TBI, emphasizing the importance of long-term follow-up in evaluating nonmyeloablative conditioning approaches. A single dose of cyclophosphamide on day 2 also significantly enhanced engraftment. When B6 TCR beta(-/-), TCR delta(-/-), or TCR beta(-/-)/delta(-/-) (CD45.2) mice were transplanted with CD45.1 bone marrow, significantly enhanced engraftment occurred in recipients lacking alpha beta-TCR(+) T cells (p < .00005). Similarly, removal of alpha beta-TCR(+) host T cells in wild-type recipients resulted in enhanced engraftment. Engraftment was also significantly increased in CD8(-/-) and CD4(-/-)/8(-/-) recipients (p < .0005). Taken together, these results demonstrate that alpha beta-TCR(+) and CD8(+) T cells play a critical role in regulating engraftment of CD45 congenic marrow and suggest that these cells are the main effector cells in low-level alloreactivity to the CD45 disparity. 相似文献
99.
100.